Amgen, Inc. (NASDAQ:AMGN) is preparing to face the Federal Drug Agency with regards to the safety of its cholesterol drug.
The U.S. regulatory body will…
An analyst from a Deutsche Bank stated that Pharmaceutical company Pfizer Inc. (NYSE:PFE), would reap a lot of benefits if it were to acquire its rival…
German health care company Merck & Co., Inc. (NYSE:MRK) has high hopes on its mission to successfully develop its anti-PDL1 immuno- oncology treatment…
Celgene Corporation (NASDAQ:CELG) has started reaping results of the joint ventures with pharmaceutical companies for cancer-curing drugs, according to…
Pfizer Inc. (NYSE:PFE) has been in talks to acquire the Swedish rare disease specialists Sobi. Sobi has an estimated worth of $4.3 billion. The company…
The pressure from activist investors Bill Ackman has forced Zoetis Inc (NYSE:ZTS) to cut as many as 2500 jobs over the next 18 months time. As per the…
Pfizer Inc. (NYSE:PFE) is one pharmaceutical company that seems to be doing everything right. Recently, the company reported an increase in sales and also…
A trial of Bristol-Myers Squibb Co (NYSE:BMY) Opdivo treatment has been concluded after proving it is effective against one of the most common forms of…
Pfizer Inc. (NYSE:PFE), ended the session with a modest gain of 1.17% yesterday, a continuation of the long term uptrend. The stock is nearly 15% up on…
Recently, Forbes reported that some of the top most Pharma companies of today, i.e., Pfizer Inc. (NYSE:PFE) and Eli Lilly and Co (NYSE:LLY) were the original…
